Arkolith/Insider Trading/CTMX/Form 4

Chu Yu-Waye

Chief Medical OfficerCytomX Therapeutics, Inc. (CTMX) · full profile →Form 4 · filed Feb 6, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2025Grant(A)58K—$0140K
Feb 4, 2025Grant(A)56K—$082K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 4, 2025Grant(A)238K—$0238K
Feb 4, 2025Grant(A)115K—$0115K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000018) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML